Skip to main content
. 2022 Feb 12;16(8):1306–1320. doi: 10.1093/ecco-jcc/jjac027

Figure 4.

Figure 4.

[A] Preclinical and clinical opportunities in inflammatory bowel disease [IBD] exposome research. [B] Omic data generation tailored to the wide range of IBD disease attributes which can be either static [like disease location] or dynamic [disease behaviour, response to therapy, perianal manifestations for example]. a, 88; b, 89; c, 22,90,91; d, 92,93; e, 90; f, 89,94–97; g, 98–107; h, 108–110; I, 111,112; j, 111–115; k, 116,117. Numbers in superscript indicate the studies which have integrated at least two omic layers to study the corresponding disease attribute.